Glenmark Pharma transfers API business to Glenmark Life Sciences

02 Jan 2019 Evaluate

Glenmark Pharmaceuticals has transferred its Active Pharmaceuticals Ingredient (API) business to Glenmark Life Sciences, a wholly owned subsidiary of the company. This transfer was completed on December 31, 2018.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1789.65 29.80 (1.69%)
11-Oct-2024 15:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1902.10
Dr. Reddys Lab 6607.00
Cipla 1597.35
Lupin 2221.40
Zydus Lifesciences 1063.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.